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Introduction
Peptoids are small molecules physically analogous to peptides.1 The benefits of using
peptoids are vast as they are highly customizable and can be made into foldamers. Foldamers are
artificial systems that self-organize into stable secondary structures usually characterized by
having a molecular surface area larger than their organic counterparts. These foldamers are
tunable in terms of orientation of side-chain functional groups.2 Both peptoids and foldamers
have uses in a plethora of industries - medicine, material science, chemical processing, energy,
etc. Investigating the characteristics of different peptoids in different conformations is necessary
for the growth of the field of nano- and micro-systems.

Figure 1 - Molecular Structure of the P3 Peptoid 3
P3 is the peptoid investigated throughout this paper. Its composition is essentially a polyN-substituted glycine backbone consisting of three different side chains: L (-)-alphamethylbenzylamine (F), tert-butyl N-(4-aminobutyl) carbamate (K), and 4-methoxybenzylamine
(M). The sequence of these twelve side chains is F M F F K F F M F F K F. A molecular diagram

1

Orwell. (1995). The ‘peptoid’ approach.

2

Mandity et al. (2015). An overview of peptide and peptoid foldamers.

3

Herbert et al. (2013). Tunable peptoid microspheres.
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for the peptoid can be seen above in Figure 1. The established molecular weight of P3 is 1,919
daltons. These peptoids have an achiral backbone and can form stable helices. These helices are
able to interacting with neighboring helices to form microspheres presumably due to stacking of
the aromatic groups. A diagram of this self-assembly process can be seen in Figure 2.

Figure 2 - Sphere Formation From Helices 4

This paper will examine the synthesis, purification, and characterization of the P3
peptoid. The characterization will focus on the robustness of P3 microspheres. High robustness
of a peptoid is essential to its viability for drug delivery. After the peptoids have been
synthesized and conformed into microspheres, the peptoids can be taken out of solution. The
peptoids can then be brought back into solutions containing the desired drug. This allows the
drug to be encapsulated inside the microspheres.

4

Herbert et al. (2013). Tunable peptoid microspheres.
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Methodology
Synthesis
The synthesis process begins with the equipment set-up. The main piece of synthesis
equipment is the reaction vessel. This vessel has a drain that can be opened into a beaker. A
nitrogen inlet stream allows for mixing in the reaction vessel. An attached vacuum system allows
for the reaction vessel to drain effectively. After the equipment is arranged, the solutions of side
chains need to be prepared. As there are eight F side-chains, the F solution is 1M 35 mL in
dimethylformamide (DMF). As there are two K side-chains, the K solution is 1M 10 mL in DMF.
As there are two M side-chains, the M solution is 0.2M 10 mL in DMF.
The rink amide resin is then prepared at a ratio dependent on the millimoles per
milligram of the resin. Resin is essentially the base for the peptoid to be built upon. The resin
used had a substitution ratio 0.79 mmol/mg. Using the sample equation for a 0.25 mol peptide
synthesis (Equation 1), the milligrams of resin required for a desired amount of synthesized
peptoid can be calculated. The resin is then added to the reaction vessel and swelled via mixing
and suspension with DMF.

Equation 1 - Sample Resin Calculation
The next step is Fmoc deprotection which is necessary for the upcoming additions of
side-chains. 0.8 milliliters of piperidine in 3.2 milliners of DMF is suspended in resin. This step
is then repeated with an extended suspension period. Several DMF washes follow to ensure the
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piperidine has been removed from the reaction vessel. The piperidine effectively renders the
resin able to attach side-chains to its surface; however, left-over piperidine would destroy the
incoming side-chains. Bromoacetic acid (BAA) is then added to the vessel to prepare the resin
for the upcoming addition reactions.
The addition of a side-chain is a combination of both bromoacetylation and coupling
steps. The bromoacetylation is achieved by combining N,N’-Diisopropylcarbodiimide (DIC) and
BAA. A DMF wash follows the bromoacetylation before the addition can take place. The
coupling begins by adding the side-chain solution to the vessel. A DMF wash follows the
coupling step. This two step cycle is repeated for each side-chain in the desired order. After the
addition of the final side chain, a dichloromethane (DCM) wash effectively ends the reaction
process by blocking off the amine group in the final F group. The resin is then dried and stored in
a vial at -20°C.
A test cleavage is then undergone to provide a sample for matrix-assisted laser
deprotonation/ionization (MALDI) and analytical high-performance liquid chromatography
(HPLC) characterization. These tests ensure the synthesis was performed correctly. The cleavage
process is described in-full below.
Cleavage
The cleavage process begins by measuring a third of the freshly synthesized peptoid-resin
complex and placing it into a vial. A mixture of triisopropylilane (TIS) and water is created in a
separate vial. Trifluoroacetic acid (TFA) is then added to this mixture. This multicomponent
mixture is then combined with the resin-peptoid complex, which is subsequently placed on a
belly dancer for vigorous mixing. This step allows for the peptoid to be separated from the resin.
!7

Then, the resin is filtered from the solution via a filter column. The solution is filtered into a
rotovap glass so that it can be transformed into its oil state. An equimolar solution of water and
acetonitrile is added to the peptoid. The amount of solution added is dependent upon the initial
resin weight, as a solution concentration of three milligrams per milliliter is desired. The peptoid
solution is then refrigerated.
Purification
The peptoid is purified using a preparative HPLC. Once the equipment has been turned
on, the feed is sparged to removed all air from the lines. A blank is sent into the system to
calibrate the machine. After the blank has been run, the purification can begin. The HPLC is able
to separate the peptoid from the other components of the solution. The purified HPLC is sent to
the fraction collector where it is placed in tubes. The fraction collector is set to move to another
tube every ten seconds. The limit considered pure for this research was 0.2 Absorbance Units
(AU). Sample data for an HPLC run for P3 is found in the Data section (Table 1).
Characterization
The initial MALDI and analytical HPLC synthesis checks proved a proper synthesis over
the course of eight different syntheses. Results from a MALDI P3 presence check can be found
in the Data section (Figure 3). This data shows that a molecule of 1,917 daltons is present in the
sample. This measurement has a two dalton discrepancy from the 1,919 dalton molecular weight
of P3. As the two amine groups in the K side-chains can be deprotonated during the process, this
two dalton difference can be justified.
To measure the robustness of the microspheres, dried P3 is diluted in a mixture of ethanol
and water. This suspension allows for the P3 peptoids to take on the secondary structure of
!8

helices. This solution is then spotted on a glass slide which is placed inside a humid chamber to
allow for the helices to come together as microspheres. After the solution is spotted on a glass
slide, the remaining peptoid mixture is lyophilized to return the peptoid to its dry state. This
process is repeated several times to examine the changes in microsphere morphology after each
round of lyophilization. The slides of microspheres were imaged using a scanning electron
microscope (SEM).

Results & Discussion
The main results from this study are the SEM images of the microspheres at each stage of
the process from pre-lyophilization to after the second lyophilization. The images can be seen in
the Data section in Figure 4. The distinct spherical morphology is retained after two rounds of
lyophilization. It should be noted that the spheres and peptoids were both absent after a third
round of lyophilization. This is most likely due to some unnoticed error in the lab that caused the
spheres not to form. If the spheres were able to form again after two rounds of lyophilization,
they can be considered robust. More of this type of testing should be performed; however, the
primary results make P3 look promising as a robust peptoid option.
After many purifications of P3, it became clear that the majority of the pure component
came out between the first and third peaks of AU. The samples around the second peak tended to
have the highest overall purity and behaved more as expected. A program could be created to
decrease the run time for the preparatory HPLC without losing volume of P3 by focusing on this
more purified range. The peaks before the first major peak were often other components that had
not been washed away.
!9

Future research should investigate how the spheres are able to form in aqueous solutions,
as well as, the degradation rates of the P3 microspheres. This first objective would be
accomplished easily enough by seeing if the spheres self-assemble in various aqueous solutions
such as phosphate-buffered saline. This second objective could be accomplished by
encapsulating a colored solution, leaving the peptoids in homeopathic conditions, and measuring
the absorbance of samples from the environmental solution over time.

Conclusion
As peptoids and foldamers become increasingly characterized, their utility will continue
to increase in a wide variety of fields. P3 itself shows much potential in many different
biomedical applications based on its folder ability. The extensive synthesis and purification
methods of P3 are feasible in any laboratory with the proper equipment; therefore, it can
continue to be synthesized and characterized for any number of studies involving nano-systems.
The characterization of robustness for P3 increases its academic value even further. Overall, P3
is a peptoidic foldamer that shows future potential in many fields, in part because of its ability to
form microspheres both consistently and robustly.
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Figure 3 - MALDI Results
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Vial Number

Start (AU)

End (AU)

Notes

1

0.2000

0.2000

Peaked at approximately 0.2198 AU

2

0.2000

0.2200

3

0.2200

0.2345

4

0.2345

0.2635

5

0.2635

0.2981

6

0.2981

0.3552

7

0.3552

0.4801

8

0.4801

0.6173

9

0.6173

0.7445

10

0.7445

0.9024

11

0.9024

0.8922

12

0.8922

0.8200

13

0.8200

0.7321

14

0.7321

0.8289

15

0.8289

1.2822

16

1.2822

1.6652

17

1.6652

2.2215

18

2.2215

2.2485

19

2.2485

1.8568

20

1.8568

1.4058

21

1.4058

1.0336

22

1.0336

0.7434

23

0.7434

0.5786

24

0.5786

0.7061

25

0.7061

1.0273

26

1.0273

1.3974

27

1.3974

1.9249

28

1.9249

1.9103

29

1.9103

1.5476

30

1.5476

1.0566

31

1.0566

0.6254

32

0.6254

0.3593

33

0.3593

0.2000

Contained the first peak

Contained the second peak

Contained the third peak

Table 1 - HPLC P3 Results
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Figure 4 - SEM imaging of the peptoid microspheres pre-lyophilization
(A & B), one round of lyophilization (C & D), and two rounds of
lyophilization (E & F)
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NOMENCLATURE

AU

Absorbance units

BAA

Bromoacetic acid

DMF

Dimethylformamide

DCM

Dichloromethane

DIC

N,N’-diisopropylcarbodiimide

F

L (-)-alpha-methylbenzylamine

HPLC

High-Performance Liquid Chromatography

K

Tert-butyl N-(4-aminobutyl) carbamate

M

4-methoxybenzylamine

MALDI

Matrix-assisted Laser Desorption/Ionization

SEM

Scanning Electron Microscope

TFA

Trifluoroacetic acid

TIS

Triisopropylsilane
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